🇺🇸 FDA
Patent

US 8841273

Methods and compositions for anti-EGFR treatment

granted A61PA61P35/00

Quick answer

US patent 8841273 (Methods and compositions for anti-EGFR treatment) held by The Board of Regents of the University of Texas System expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00